Hypoglycaemia in adult vs. elderly type 2 diabetes mellitus patients: risks, costs, and impact on treatment persistence in a US population

被引：0
|
作者：
Bron, M. [1 ]
Marynchenko, M. [2 ]
Yang, H. [2 ]
Yang, Y. [1 ]
Wu, E. [2 ]
Yu, A. P. [2 ]
机构：
[1] Takeda Pharmaceut Int Inc, Global Hlth Econ & Outcomes Res, Deerfield, IL USA
[2] Anal Grp Inc, Boston, MA USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
651
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [31] Type 2 diabetes mellitus in elderly institutionalized patients
    Cano Megias, M.
    Guisado Vasco, P.
    REVISTA CLINICA ESPANOLA, 2014, 214 (09): : 521 - 528
  • [32] Deprescription in elderly patients with type 2 diabetes mellitus
    Silverii, Giovanni Antonio
    Caldini, Eleonora
    Dicembrini, Ilaria
    Pieri, Maria
    Monami, Matteo
    Mannucci, Edoardo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [33] Use of Pioglitazone vs. Placebo in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis Treatment
    Pfuetzner, Anke H.
    Schoendorf, Thomas
    Dikta, Gerhard
    Krajewski, Vera
    Fuchs, Winfried
    Forst, Thomas
    Pfuetzner, Andreas
    Galle, Jan
    DIABETES, 2011, 60 : A315 - A316
  • [34] Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus
    Bonilla, E.
    Lee, Y. Y.
    Phillips, P. E.
    Perl, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (12) : 1688 - 1688
  • [35] Insulin resistance is greater in type 2 vs. type 1.5 diabetes mellitus
    Stoever, JA
    Palmer, JP
    DIABETES, 2002, 51 : A559 - A560
  • [36] Resource Utilization and Costs of Type 1 and Type 2 Diabetes Mellitus (DM) Patients vs. Non-DM Patients in the Hospital and Post-Discharge
    Yurgin, Nicole R.
    Foster, Shonda A.
    Ernst, Frank R.
    Iorga, Serban R.
    Jackson, Jeffrey A.
    DIABETES, 2009, 58 : A597 - A597
  • [37] Population pharmacokinetics of rosiglitazone in adult and adolescent patients with type 2 diabetes mellitus.
    Chm, J.
    Johnson, B. M.
    Patel, B. R.
    Miller, A. K.
    Mudd, P. N.
    Hoke, J. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S94 - S94
  • [38] Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus
    Van De Ree, MA
    De Maat, MPM
    Kluft, C
    Meinders, AE
    Princen, HMG
    Huisman, MV
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (08) : 1753 - 1757
  • [39] Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study
    Sardu, Celestino
    Paolisso, Pasquale
    Santamaria, Matteo
    Sacra, Cosimo
    Pieretti, Gorizio
    Rizzo, Maria Rosaria
    Barbieri, Michelangela
    Scisciola, Lucia
    Nicoletti, Gianfranco
    Paolisso, Giuseppe
    Marfella, Raffaele
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 151 : 152 - 162
  • [40] Treatment of Elderly Patients With Type 2 Diabetes Mellitus: A Systematic Review of the Benefits and Risks of Dipeptidyl Peptidase-4 Inhibitors
    Schwartz, Sherwyn L.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (05): : 405 - 418
12345